Insight into how three of the world's most devastating viruses interact with human cells opens the door for much-needed treatments
Lotus Clinical Research LLC receives private equity backing; expands team with Jeffrey Kinell and Kurt Brykman joining board of directors
Lotus Clinical Research Presented at Pain Therapeutics in San Francisco on Development of Long-Acting Local Anesthetics
Parnell delivers 39% revenue growth and a $5.9 million year-to-date improvement in EBITDA as at the third quarter of 2018 compared to the same period in 2017, consolidates the return to profitability, and maintains full-year 2018 guidance at a 35 - 40% increase over 2017 revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million.
Researchers will use IASLC/LCFA funds to create new lung cancer treatments for never-smokers and patients whose cancer has spread
IDTechEx will be hosting a masterclass on Bioelectronics & Neuroprosthetics at the Santa Clara Convention Center, CA
The NIH funds an initiative at the Gladstone Institutes to assess the safety of CRISPR-like therapies in human tissues
OccuPro's FCE is used for assessing a client's readiness to return to work.
With generous support for research funding, The Ehlers-Danlos Society sponsors International Symposium in Ghent, Belgium, to accelerate collaborative global research into EDS, HSD, their related symptoms and associated conditions.
Food Allergy Research & Education's Collaborative to Advance Food Allergy Research Continues to Grow
Scientists from the Gladstone Institutes discover how to enhance the longevity of cells that kill tumors and infected cells
A team of scientists from the Gladstone Institutes, UCSF, and UC Berkeley identify nearly 200 potential drug targets
BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders
Jan-Eric Ahlfors, CEO of Fortuna Fix Inc., to present at IABS/CIRM 4th Cell Therapy Conference on June 6, 2018 in Los Angeles
One of America's foremost oncologists leads this webinar series on the past, the present and the future of immunotherapy studies
The Childhood Cancer Project raises $100,000 for childhood cancer research.